149 related articles for article (PubMed ID: 36695557)
61. Extra-articular involvement of rheumatoid arthritis in three seropositive patients in the absence of initial joint involvement.
Chirila RM; Berianu F; Abril A; Butendieck RR
Immun Inflamm Dis; 2021 Dec; 9(4):1613-1617. PubMed ID: 34473908
[TBL] [Abstract][Full Text] [Related]
62. Use of Cerebrospinal Fluid Biomarkers in Diagnosis and Monitoring of Rheumatoid Meningitis.
Nissen MS; Nilsson AC; Forsberg J; Milthers J; Wirenfeldt M; Bonde C; Byg KE; Ellingsen T; Blaabjerg M
Front Neurol; 2019; 10():666. PubMed ID: 31293505
[TBL] [Abstract][Full Text] [Related]
63. Anti-Cyclic Citrullinated Peptide Antibody Index in the Cerebrospinal Fluid for the Diagnosis and Monitoring of Rheumatoid Meningitis.
Caputi L; Boncoraglio GB; Bernardi G; Ciusani E; Dantes M; de Liso F; Erbetta A; Marucci G; Matinato C; Corsini E
Biomedicines; 2022 Sep; 10(10):. PubMed ID: 36289663
[TBL] [Abstract][Full Text] [Related]
64. Identification of Subclinical Lung Involvement in ACPA-Positive Subjects through Functional Assessment and Serum Biomarkers.
Lucchino B; Di Paolo M; Gioia C; Vomero M; Diacinti D; Mollica C; Alessandri C; Diacinti D; Palange P; Di Franco M
Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32708286
[TBL] [Abstract][Full Text] [Related]
65. In Rheumatoid Arthritis Patients, HLA-DRB1*04:01 and Rheumatoid Nodules Are Associated With ACPA to a Particular Fibrin Epitope.
Larid G; Pancarte M; Offer G; Clavel C; Martin M; Pradel V; Auger I; Lafforgue P; Roudier J; Serre G; Balandraud N
Front Immunol; 2021; 12():692041. PubMed ID: 34248985
[TBL] [Abstract][Full Text] [Related]
66. Association between levels of synovial anti-citrullinated peptide antibodies and neutrophil response in patients with rheumatoid arthritis.
Gorlino CV; Dave MN; Blas R; Crespo MI; Lavanchy A; Tamashiro H; Pardo-Hildalgo R; Pistoresi-Palencia MC; Di Genaro MS
Eur J Immunol; 2018 Sep; 48(9):1563-1572. PubMed ID: 29879311
[TBL] [Abstract][Full Text] [Related]
67. Prediction models for rheumatoid arthritis during diagnostic investigation: evaluation of combinations of rheumatoid factor, anti-citrullinated protein/peptide antibodies and the human leucocyte antigen-shared epitope.
Vander Cruyssen B; Hoffman IE; Peene I; Union A; Mielants H; Meheus L; De Keyser F
Ann Rheum Dis; 2007 Mar; 66(3):364-9. PubMed ID: 16840502
[TBL] [Abstract][Full Text] [Related]
68. The role of anti-citrullinated protein antibody reactivities in an inception cohort of patients with rheumatoid arthritis receiving treat-to-target therapy.
Jonsson MK; Hensvold AH; Hansson M; Aga AB; Sexton J; Mathsson-Alm L; Cornillet M; Serre G; Lillegraven S; Fevang BS; Catrina AI; Haavardsholm EA
Arthritis Res Ther; 2018 Jul; 20(1):146. PubMed ID: 30001740
[TBL] [Abstract][Full Text] [Related]
69. Rheumatoid factor and anti-citrullinated peptide antibodies in the general population: hepatitis B and C virus association and 15-year-risk of rheumatoid arthritis.
Generali E; De Santis M; Isailovic N; Palermo B; Guidelli GM; Ceribelli A; Alborghetti F; Colloredo G; Porrati L; Matthias T; Zucchi A; Selmi C
Clin Exp Rheumatol; 2021; 39(1):38-43. PubMed ID: 33337995
[TBL] [Abstract][Full Text] [Related]
70. The prevalence of ACPA is lower in rheumatoid arthritis patients with an older age of onset but the composition of the ACPA response appears identical.
Boeters DM; Mangnus L; Ajeganova S; Lindqvist E; Svensson B; Toes REM; Trouw LA; Huizinga TWJ; Berenbaum F; Morel J; Rantapää-Dahlqvist S; van der Helm-van Mil AHM
Arthritis Res Ther; 2017 May; 19(1):115. PubMed ID: 28569212
[TBL] [Abstract][Full Text] [Related]
71. The family history of rheumatoid arthritis in anti-cyclic citrullinated peptide antibody-positive patient is not a predictor of poor clinical presentation and treatment response with modern classification criteria and treatment strategy: the ANSWER cohort study.
Murata K; Hashimoto M; Yamamoto W; Son Y; Amuro H; Nagai K; Takeuchi T; Katayama M; Maeda Y; Ebina K; Hara R; Jinno S; Onishi A; Murakami K; Tanaka M; Ito H; Mimori T; Matsuda S
Rheumatol Int; 2020 Feb; 40(2):217-225. PubMed ID: 31620864
[TBL] [Abstract][Full Text] [Related]
72. Titer-Dependent Effect of Anti-Citrullinated Protein Antibodies On Systemic Bone Mass in Rheumatoid Arthritis Patients.
Orsolini G; Caimmi C; Viapiana O; Idolazzi L; Fracassi E; Gatti D; Adami G; Rossini M
Calcif Tissue Int; 2017 Jul; 101(1):17-23. PubMed ID: 28246933
[TBL] [Abstract][Full Text] [Related]
73. Anti-cyclic citrullinated peptide antibody-positive rheumatoid arthritis caused by bacterial organizing pneumonia in a patient with Sjogren's syndrome.
Horino T; Yoshida M; Inotani S; Anabuki K; Ohnishi H; Komori M; Ichii O; Terada Y
Rom J Intern Med; 2022 Jun; 60(2):127-131. PubMed ID: 35092658
[TBL] [Abstract][Full Text] [Related]
74. Autoantibodies are major predictors of arthritis development in patients with anti-citrullinated protein antibodies and musculoskeletal pain.
Eloff E; Martinsson K; Ziegelasch M; Cedergren J; Reckner Å; Skogh T; Karlsson L; Ärlemalm A; Borggreven NV; Trouw LA; Kastbom A
Scand J Rheumatol; 2021 May; 50(3):189-197. PubMed ID: 33243072
[No Abstract] [Full Text] [Related]
75. Autoantibodies in Rheumatoid Arthritis - Laboratory and Clinical Perspectives.
Rönnelid J; Turesson C; Kastbom A
Front Immunol; 2021; 12():685312. PubMed ID: 34054878
[TBL] [Abstract][Full Text] [Related]
76. Current view on the pathogenic role of anti-citrullinated protein antibodies in rheumatoid arthritis.
Catrina A; Krishnamurthy A; Rethi B
RMD Open; 2021 Mar; 7(1):. PubMed ID: 33771834
[TBL] [Abstract][Full Text] [Related]
77. An unusual presentation of rheumatoid meningitis.
Chowdhry V; Kumar N; Lachance DH; Salomao DR; Luthra HS
J Neuroimaging; 2005 Jul; 15(3):286-8. PubMed ID: 15951415
[TBL] [Abstract][Full Text] [Related]
78. [Case of rheumatoid meningitis: findings on diffusion-weighted image versus FLAIR image].
Matsuura D; Ohshita T; Nagano Y; Ohtsuki T; Kohriyama T; Matsumoto M
Rinsho Shinkeigaku; 2008 Mar; 48(3):191-5. PubMed ID: 18409539
[TBL] [Abstract][Full Text] [Related]
79. Past infections are associated with low levels of anti-citrullinated protein autoantibodies in rheumatoid arthritis.
Tani K; Kanamori M; Nagase Y; Okura Y; Kawaminami S; Kawahito K; Inaba K; Inaba K; Miyatake A; Kondo K; Tabata R; Suzuki Y; Yamaguchi H
J Med Invest; 2020; 67(1.2):182-188. PubMed ID: 32378604
[TBL] [Abstract][Full Text] [Related]
80. A novel bedside test for ACPA: the CCPoint test is moving the laboratory to the rheumatologist's office.
Zandman-Goddard G; Soriano A; Gilburd B; Lidar M; Kivity S; Kopilov R; Langevitz P; Shoenfeld Y; Agmon-Levin N
Immunol Res; 2017 Feb; 65(1):363-368. PubMed ID: 27470303
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
